BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-353@pharmaconomics
DTSTAMP:20260707T034541Z
DTSTART;VALUE=DATE:20251231
DTEND;VALUE=DATE:20260101
SUMMARY:VSTM Approval — avutometinib capsules\; defactinib tablets
DESCRIPTION:A final FDA approval decision on avutometinib capsules\; defactinib tablets for adult patients with Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant-type (mt) recurrent Low-Grade Serous Ovarian Cancer (LGSOC) is expected Dec 31\, 2025.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1526119/000110465926023462/tm267866d1_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/353
URL:https://www.pharmaconomics.com/e/353
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:VSTM catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR